Financial comparisons Celltrion, Inc.
Equities
A068270
KR7068270008
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 199,700.00 KRW | -0.89% |
|
+2.25% | +10.33% |
| Apr. 08 | Nomura Adjusts Celltrion's Price Target to KRW270,000 From KRW240,000, Keeps at Buy | MT |
| Apr. 03 | South Korean shares fall for second week on Middle East worries | RE |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 2.88B | 24.74% | 28.07% | 5.94% | 4.75% | 2.2x | |
| 8.24B | 14.53% | 21.7% | 10.28% | 4.9% | 1.58x | |
| 5.34B | 5.37% | 8.37% | 29.84% | 16.27% | -5.99x | |
| 16.31B | 8.34% | 13.38% | 32.9% | 4.79% | 3.63x | |
| 846M | -31.67% | -18.92% | - | - | 1.57x | |
| 2.53B | 17.83% | 20.93% | 70.23% | 22.13% | -0.89x | |
| 8.57B | 6.51% | 14.79% | 9.61% | 4.34% | 2.22x | |
| 944M | -40.36% | -40.47% | -70.72% | -11.67% | 4.51x | |
| 14.56M | -2,710.48% | -1,984.68% | -102.78% | - | 2.2x | |
| 1.22B | 6.02% | 31.45% | 15.37% | 11.65% | 0.43x | |
| 4.02B | -3.59% | 19.77% | 15.46% | 6.99% | 1.98x | |
| 2.09B | 20.33% | 29.46% | 17.5% | 10.73% | 0.74x | |
| 8.28B | 9.56% | 19.29% | 12.39% | 6.87% | 1.66x | |
| 1.27B | -19.27% | -3.71% | -38.64% | -6.61% | -65.61x | |
| 2.02B | 11.8% | 13.68% | 11.6% | 6.52% | 1.81x | |
| 39.21M | -794.04% | -891.07% | -25.78% | -22.89% | 4.75x | |
| 977M | 12.99% | 14.77% | 4.29% | 3.11% | -0.37x | |
| Average | 3.86B | -203.61% | -159.01% | -0.16% | 4.13% | -2.56x | |
| Weighted average by Cap. | 5.42B | -117.7% | -86.25% | 7.82% | 6.04% | -1.01x |
- Stock Market
- Equities
- A068270 Stock
- Sector Celltrion, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
